galactosamine has been researched along with oridonin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Liu, S; Mao, Z; Tang, L; Wen, Y; Zhan, Z; Zhang, T | 1 |
| Chen, Y; Cheng, Y; Dai, F; Gu, T; Jiang, H; Tang, L; Wen, X; Zhan, Z; Zhang, T | 1 |
2 other study(ies) available for galactosamine and oridonin
| Article | Year |
|---|---|
Oridonin alleviates d-GalN/LPS-induced acute liver injury by inhibiting NLRP3 inflammasome.
Topics: Animals; Chemical and Drug Induced Liver Injury; Diterpenes, Kaurane; Galactosamine; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein | 2021 |
Effect of oridonin on oxylipins in the livers of mice with acute liver injury induced by D-galactosamine and lipopolysaccharide.
Topics: Animals; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Arachidonate 5-Lipoxygenase; Chemical and Drug Induced Liver Injury; Cyclooxygenase 1; Cyclooxygenase 2; Diterpenes, Kaurane; Galactosamine; Lipopolysaccharides; Liver; Male; Membrane Proteins; Mice, Inbred C57BL; Organic Anion Transporters; Oxylipins; Protective Agents | 2022 |